Cargando…

Reply to “Comment on ‘Current outbreak of monkeypox: essentials for the dermatologist’”

Detalles Bibliográficos
Autores principales:	Khanna, Urmi, Bishnoi, Anuradha, Vinay, Keshavamurthy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2022
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533925/ https://www.ncbi.nlm.nih.gov/pubmed/36030985 http://dx.doi.org/10.1016/j.jaad.2022.08.035

Ejemplares similares

Current outbreak of monkeypox: Essentials for the dermatologist
por: Khanna, Urmi, et al.
Publicado: (2022)

Comment on “Current outbreak of monkeypox: Essentials for the dermatologist”
por: Pathania, Yashdeep Singh
Publicado: (2022)

Clinical considerations in pediatric cases of monkeypox
por: Khanna, Urmi, et al.
Publicado: (2023)

Diagnostic considerations in suspected cases of monkeypox
por: Khanna, Urmi, et al.
Publicado: (2023)

Reply to comment on: The Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2021)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Reply to: Comments on “Proposed approach for reusing surgical masks in COVID-19 pandemic”
por: Liu, Yuangang, et al.
Publicado: (2020)

Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021)

Comment on: “Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions”
por: Fernandez-Nieto, Diego, et al.
Publicado: (2020)

Blistering exanthems in the times of monkeypox—Keep calm and do not panic!
por: Mehta, Nikhil, et al.
Publicado: (2023)

Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”
por: Ruggiero, Giuseppe, et al.
Publicado: (2020)

Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Monkeypox emerges on a global scale: A historical review and dermatologic primer
por: Bryer, Joshua S., et al.
Publicado: (2023)

Reply to: “Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Manalo, Iviensan F., et al.
Publicado: (2020)

Reply to the comment on “What are the barriers faced by underrepresented minorities applying to dermatology? A qualitative cross-sectional study of applicants applying to a large dermatology residency program”
por: Vasquez, Rebecca, et al.
Publicado: (2020)

Comment on “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”
por: Fernandez-Nieto, Diego, et al.
Publicado: (2020)

In response to: “Reply to research letter”
por: Wan, Marilyn T., et al.
Publicado: (2020)

Comment on: The Gabrin sign
por: Trüeb, Ralph M., et al.
Publicado: (2021)

Letter to the Editor regarding “Monkeypox emerges on a global scale: A historical review and dermatological primer”
por: Wang, Yaojun, et al.
Publicado: (2023)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Schultz, Brittney, et al.
Publicado: (2021)

Reply to: “A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Thomas, Cristina
Publicado: (2020)

Reply to early-onset effluvium secondary to COVID-19 and body hair effluvium
por: Wambier, Carlos Gustavo, et al.
Publicado: (2022)

Reply to: Do interleukin 17 inhibitors increase risk of respiratory tract infections?
por: Blauvelt, Andrew, et al.
Publicado: (2020)

Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?”
por: Wan, Marilyn T., et al.
Publicado: (2020)

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021)

Reply to: “Skin damage among health care workers managing coronavirus disease 2019”
por: Maliyar, Khalad, et al.
Publicado: (2020)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Reply to: “Skin damage among health care workers managing coronavirus disease-2019”
por: Oranges, Teresa, et al.
Publicado: (2020)

Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
por: Bukovac, Domen, et al.
Publicado: (2021)

Comment on: “Proposed approach for reusing surgical masks in COVID-19 pandemic”
por: Torres, Angeli Eloise, et al.
Publicado: (2020)

Invited response to the comment on “Dermatology residents and the care of COVID-19 patients”
por: Grant-Kels, Jane M.
Publicado: (2020)

Comment on “Psoriasis and COVID-19: A bidirectional Mendelian randomization study”
por: Gu, Xiaoyu, et al.
Publicado: (2023)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020)

Response to comment on “Psoriasis and COVID-19: A bidirectional Mendelian randomization study”
por: Chalitsios, Christos V., et al.
Publicado: (2023)

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
por: Pahalyants, Vartan, et al.
Publicado: (2022)

Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
por: Yousaf, Ahmed, et al.
Publicado: (2021)

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Importance of nose wires in face masks: A reply to “Diagnostic and management considerations for “maskne” in the era of COVID-19”
por: Kassamali, Bina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j1ojm4683nl503cvrcj8cc07n1